Person

John E. Gallina

Director, CVS Health

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$24.0M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 24, 2021ELVSale17,819$393.56$7.0M
May 24, 2021ELVSale8,163$394.62$3.2M
May 24, 2021ELVSale15,262$395.67$6.0M
May 24, 2021ELVSale1,100$396.50$436K
May 24, 2021ELVSale4,100$397.91$1.6M
Mar 5, 2018ELVSale15,104$229.19$3.5M
Mar 5, 2018ELVSale5,372$230.44$1.2M
Mar 5, 2018ELVSale4,100$231.29$948K

SEC reporting-owner ID (CIK) 1433032 · all filings on EDGAR

John E. Gallina (CVS) | USBoard